Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Amendment history:
  • Correction (March 1971)

Research Article Free access | 10.1172/JCI106426

Human alveolar macrophages: comparison of phagocytic ability, glucose utilization, and ultrastructure in smokers and nonsmokers

James O. Harris, Edward W. Swenson, and Joseph E. Johnson III

Division of Pulmonary Diseases, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida 32602

Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida 32602

Find articles by Harris, J. in: PubMed | Google Scholar

Division of Pulmonary Diseases, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida 32602

Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida 32602

Find articles by Swenson, E. in: PubMed | Google Scholar

Division of Pulmonary Diseases, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida 32602

Division of Infectious Diseases, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida 32602

Find articles by Johnson, J. in: PubMed | Google Scholar

Published November 1, 1970 - More info

Published in Volume 49, Issue 11 on November 1, 1970
J Clin Invest. 1970;49(11):2086–2096. https://doi.org/10.1172/JCI106426.
© 1970 The American Society for Clinical Investigation
Published November 1, 1970 - Version history
View PDF
Abstract

Phagocytic ability, glucose utilization, and ultrastructural morphology were studied in human alveolar macrophages in smokers and nonsmokers. The macrophages were obtained by bronchopulmonary lavage and the studies were carried out in vitro in the absence of smoke. Phagocytic ability was measured as the decrease in the number of viable Staphylococcus albus organisms incubated with the macrophages. Measurements of 14CO2 formation from glucose-U-14C were made in a resting state. 90-95% of the cells obtained by lavage were large mononuclear macrophages of which approximately 90% remained viable at the end of the experiment. Smokers yielded many more macrophages per lavage (mean 46.4 × 106 ±7.4) compared to the nonsmokers (mean 10.2 × 106 ±2.3). The decline in viable organisms was the same in each group, indicating phagocytic competence of alveolar macrophages removed from smokers. However, the mean glucose utilization for the smokers was 4.3 ±0.2 mμmoles/106 cells and 1.4 ±0.7 mμmoles/106 cells for the nonsmokers. This very significant difference (P < 0.0001) suggests that smokers' macrophages have a higher resting energy requirement than those of nonsmokers. Comparison of the ultrastructural morphology of the alveolar macrophages from each group reveals that the cells from smokers differ from those of nonsmokers in that they are slightly larger, and contain more golgi vesicles, endoplasmic reticulum, and residual bodies. The residual bodies in smokers' cells contain distinctive fiber-like inclusions.

Images.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 2086
page 2086
icon of scanned page 2087
page 2087
icon of scanned page 2088
page 2088
icon of scanned page 2089
page 2089
icon of scanned page 2090
page 2090
icon of scanned page 2091
page 2091
icon of scanned page 2092
page 2092
icon of scanned page 2093
page 2093
icon of scanned page 2094
page 2094
icon of scanned page 2095
page 2095
icon of scanned page 2096
page 2096
Version history
  • Version 1 (November 1, 1970): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts